
European authorities have made new proposals to allow pharma to communicate with patients and the public – but a ban …

Responsibility for pharma and biotech policy has been taken away from the European Commission’s Enterprise and Industry directorate and handed to the …
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

